← Mechanisms of action
VHL/BCR-ABL1
PROTEIN-PROTEIN INTERACTIONHomo sapiens
Linked proteins
Drugs acting on this target (5)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| hs-10382 | Antagonist | experimental | Small molecule | VHL/BCR-ABL1 antagonist |
| tgrx-678 | Antagonist | experimental | Small molecule | VHL/BCR-ABL1 antagonist |
| bcr-abl peptide vaccine | Immunity, active | experimental | Vaccine | VHL/BCR-ABL1 immunity, active |
| nilotinib (tasigna) | Inhibitor | approved | Small molecule | VHL/BCR-ABL1 inhibitor |
| rct-01 | Supplementation | experimental | Cell therapy | VHL/BCR-ABL1 supplementation |